Can Patients at Elevated Risk of Stroke Treated With Anticoagulants Be Further Risk Stratified?
Lawrence Baruch(AstraZeneca (United Kingdom)), Miguel Zabalgoitia(The University of Texas Rio Grande Valley), Jay Horrow(Wilmington University), Brian F. Gage(Washington University in St. Louis), Arthur J. Labovitz(University of South Florida), Steen Juul‐Möller(Lund University), Maria Persson(AstraZeneca (United Kingdom))
Cited by 71
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
Recommendations for Evaluation of Prosthetic Valves With Echocardiography and Doppler Ultrasound
|Journal of the American Society of Echocardiography|2009|1.3k
Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm
|New England Journal of Medicine|2012|580
Transesophageal Echocardiographic Correlates of Clinical Risk of Thromboembolism in Nonvalvular Atrial Fibrillation
|Journal of the American College of Cardiology|1998|554
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery
|Journal of the American College of Cardiology|2010|538